ImmuneOncia Therapeutics, Inc. (CEO Heung-Tae Kim) announced interim results today from the ongoing Phase 1b clinical trial of its next-generation CD47-targeting antibody, IMC-002, in combination with ...

In a report released on May 30, analyst Jason McCarthy from Maxim Group maintained a Buy rating on CERo Therapeutics Holdings ...

BDC-4182 Phase 1 dose-escalation study now open for enrollmentBDC-3042 Phase 1 dose-escalation data presented at AACR 2025 demonstrated a favorable safety profile, dose-dependent biological activity ...

Zanidatamab was previously approved by the U.S. Food and Drug Administration (FDA) in November 2024 and had a positive ...

The question of how life could have emerged is one of the most long-standing mysteries in science. In a new study, the ...

Scientists have documented the way a single gene in the bacterium that causes bubonic plague, Yersinia pestis, allowed it to ...

A change to a single gene in the bacterium Yersinia pestis has enabled one of the world’s most notorious pathogens to survive ...

We show here that in a transgenic mouse model, inflammatory mediators induced expression of FcαRI on Kupffer cells, which enabled efficient phagocytosis in vivo of bacteria coated with serum IgA.

Digital Pathology–Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer FGFR2b protein ...

"It's a spiral - the more skills you get, the more you can develop." Here are some stages that you can spot in your child during their first five years… This stage is "all about the information ...

Characterization of HER2 alterations in lung adenocarcinoma.